These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 8575508)
1. Lack of selectivity for ventricular and ischaemic tissue limits the antiarrhythmic actions of lidocaine, quinidine and flecainide against ischaemia-induced arrhythmias. Barrett TD; Hayes ES; Walker MJ Eur J Pharmacol; 1995 Oct; 285(3):229-38. PubMed ID: 8575508 [TBL] [Abstract][Full Text] [Related]
2. Ischaemia selectivity confers efficacy for suppression of ischaemia-induced arrhythmias in rats. Barrett TD; Hayes ES; Yong SL; Zolotoy AB; Abraham S; Walker MJ Eur J Pharmacol; 2000 Jun; 398(3):365-74. PubMed ID: 10862826 [TBL] [Abstract][Full Text] [Related]
3. Limited antifibrillatory effectiveness of clinically relevant concentrations of class I antiarrhythmics in isolated perfused rat hearts. Farkas A; Curtis MJ J Cardiovasc Pharmacol; 2002 Mar; 39(3):412-24. PubMed ID: 11862121 [TBL] [Abstract][Full Text] [Related]
4. Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation. Aupetit JF; Loufoua-Moundanga J; Faucon G; Timour Q Br J Pharmacol; 1997 Feb; 120(3):523-9. PubMed ID: 9031759 [TBL] [Abstract][Full Text] [Related]
5. Antifibrillatory and profibrillatory actions of selected class I antiarrhythmic agents. Fagbemi SO; Chi L; Lucchesi BR J Cardiovasc Pharmacol; 1993 May; 21(5):709-19. PubMed ID: 7685439 [TBL] [Abstract][Full Text] [Related]
6. Frequency-independent blockade of cardiac Na+ channels by riluzole: comparison with established anticonvulsants and class I anti-arrhythmics. Mestre M; Djellas Y; Carriot T; Cavero I Fundam Clin Pharmacol; 2000; 14(2):107-17. PubMed ID: 10796057 [TBL] [Abstract][Full Text] [Related]
7. Effects of Na+ channel blockers on extrasystolic stimulation-evoked changes in ventricular conduction and repolarization. Osadchii OE J Cardiovasc Pharmacol; 2014 Mar; 63(3):240-51. PubMed ID: 24220314 [TBL] [Abstract][Full Text] [Related]
8. Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol. Weissenburger J; Davy JM; Chézalviel F; Ertzbischoff O; Poirier JM; Engel F; Lainée P; Penin E; Motté G; Cheymol G J Pharmacol Exp Ther; 1991 Nov; 259(2):871-83. PubMed ID: 1941633 [TBL] [Abstract][Full Text] [Related]
9. The cutaneous analgesic effect of class I antiarrhythmic drugs. Tzeng JI; Cheng KI; Huang KL; Chen YW; Chu KS; Chu CC; Wang JJ Anesth Analg; 2007 Apr; 104(4):955-8. PubMed ID: 17377113 [TBL] [Abstract][Full Text] [Related]
10. Effects of flecainide on ventricular arrhythmias, abnormal automaticity and activation in a canine model of myocardial infarction. Hashimoto H; Katoh H; Nakashima M J Pharmacobiodyn; 1992 May; 15(5):191-201. PubMed ID: 1527695 [TBL] [Abstract][Full Text] [Related]
11. K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes. Slawsky MT; Castle NA J Pharmacol Exp Ther; 1994 Apr; 269(1):66-74. PubMed ID: 8169853 [TBL] [Abstract][Full Text] [Related]
12. Ventricular arrhythmia incidence in the rat is reduced by naloxone. Pugsley MK; Hayes ES; Wang WQ; Walker MJ Pharmacol Res; 2015 Jul; 97():64-9. PubMed ID: 25920674 [TBL] [Abstract][Full Text] [Related]
14. Effects of Org 7797 on early, late and inducible arrhythmias following coronary artery occlusion in rats and dogs. Winslow E; Campbell JK; Barron E; Marshall RJ; Muir AW Br J Pharmacol; 1991 Dec; 104(4):853-8. PubMed ID: 1810599 [TBL] [Abstract][Full Text] [Related]
15. Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart. Farkas A; Qureshi A; Curtis MJ Br J Pharmacol; 1999 Sep; 128(1):41-50. PubMed ID: 10498833 [TBL] [Abstract][Full Text] [Related]
16. A new ECG measure (RSh) for detecting possible sodium channel blockade in vivo in rats. Penz W; Pugsley M; Hsieh MZ; Walker MJ J Pharmacol Toxicol Methods; 1992 Mar; 27(1):51-8. PubMed ID: 1316193 [TBL] [Abstract][Full Text] [Related]
17. Effects of flecainide on atrial and ventricular refractoriness in rabbits in vitro and in vivo. Leung MW; Chan AP; So PP; Lowe GC; Guppy LJ; Walker MJ Proc West Pharmacol Soc; 2004; 47():42-5. PubMed ID: 15633609 [TBL] [Abstract][Full Text] [Related]
18. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome. Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304 [TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic and electrophysiologic actions of flecainide in animal models. Kvam DC; Banitt EH; Schmid JR Am J Cardiol; 1984 Feb; 53(5):22B-25B. PubMed ID: 6695815 [TBL] [Abstract][Full Text] [Related]
20. Effects of an antiarrhythmic drug A-2545 on canine ventricular arrhythmia models; comparison with mexiletine and flecainide. Xue YX; Arita J; Aye NN; Hashimoto K Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):649-56. PubMed ID: 9879724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]